Photoimmunotherapy for Immunosuppressed Patients and Prevalent and Commonly Known Cancers

Tumors have become more common in recent years across the world. Although immunotherapy is a precise, quick, and efficient way to treat tumors, it generates serious side effects, such as cytokine release syndrome (CRS) and neurotoxicity. Thus, the creation of an efficient and non-harmful immunotherapy approach is urgently required. Photochemical interactions—especially photodynamic therapy (PDT) and photothermal therapy (PTT)—can be used for direct cell killing in treating malignancies.

“The leading market participants in the worldwide PIT market include”… “Modulight Corporation”…